뉴욕의 신경모세포종 임상 시험
신경모세포종 관련 연구 15개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.
뉴욕의 도시
공식 연구 텍스트(영어)
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Columbia University Medical Center, New York
피험자 모집 중
17세 이하 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT06831552A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중2상건강한 지원자 환영
전 연령 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT04936529A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
- Memorial Sloan Kettering Suffolk-Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 외 1개
피험자 모집 중2상
전 연령 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT06057948Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중1/2상
1세 ~ 30세 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07437963Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Albany Medical Center, Albany
- Roswell Park Cancer Institute, Buffalo
- NYU Langone Hospital - Long Island, Mineola
- 외 7개
피험자 모집 중3상
30세 이하 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Memorial Sloan Kettering Cancer Center ( Site 1010), New York
- New York Medical College ( Site 1023), Valhalla
피험자 모집 중1/2상
6 Months – 25 Years · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT06395103Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT00588068N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중2상
18 Months – 19 Years · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT06528496Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- Roswell Park Cancer Institute, Buffalo
- 외 8개
피험자 모집 중3상
365 Days – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
피험자 모집 중1/2상
12 Months – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04851119SPEARHEAD-3 Pediatric Study
- Memorial Sloan Kettering Kids, New York
피험자 모집 중1/2상
2세 ~ 21세 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05642455Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- Memorial Sloan Kettering Cancer Center, New York
피험자 모집 중2상
1세 이상 · 모든 성별 · 2026. 5. 29. 업데이트됨 · NCT00107289Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- New York Medical College, Valhalla
피험자 모집 중1상
1세 ~ 30세 · 모든 성별 · 2026. 4. 15. 업데이트됨 · NCT04308330Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
피험자 모집 중2상
1세 ~ 50세 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT01804634A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
피험자 모집 중2상
18 Months – 40 Years · 모든 성별 · 2025. 8. 12. 업데이트됨 · NCT05135975ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.